Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Comparison of aspirin and pentoxifylline for claudication

April 23, 1997

Balanced ETA/ETB antagonist from Abbott

April 22, 1997

Merck KGaA prepares cardioprotective agents

April 22, 1997

PGE1 derivatives for peripheral circulatory disorders from Ono

April 22, 1997

Teva receives FDA approval for antihypertensive generic

April 22, 1997

NitroMed and Cordis collaborate to develop novel cardiovascular products

April 18, 1997

Biovail's Tiazac approved and introduced in Canada

April 17, 1997

Celgene reports dual TNF/PDE inhibitors

April 17, 1997

Defibrillators associated with reduced mortality compared to antiarrhythmic drugs

April 17, 1997

Potent and selective ETA antagonist from SKB

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...